Skip to Content

93 294 (Carbidopa and Levodopa 25 mg / 250 mg)

Pill with imprint 93 294 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 294

Carbidopa and levodopa 25 mg / 250 mg 93 294  Front
Carbidopa and levodopa 25 mg / 250 mg 93 294  Back
Carbidopa and levodopa 25 mg / 250 mg 93 294
Carbidopa and levodopa 25 mg / 250 mg 93 294

Carbidopa and Levodopa

Imprint:
93 294
Strength:
25 mg / 250 mg
Color:
Blue
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
corn starch
FD&C Blue No. 2
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0048 McKesson Packaging Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide